High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group (Q36200306)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group |
scientific article |
Statements
1 reference
High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group (English)
1 reference
George S Laszlo
1 reference
Todd A Alonzo
1 reference
Chelsea J Gudgeon
1 reference
Kimberly H Harrington
1 reference
Alex Kentsis
1 reference
Robert B Gerbing
1 reference
Yi-Cheng Wang
1 reference
Rhonda E Ries
1 reference
Susana C Raimondi
1 reference
Betsy A Hirsch
1 reference
Alan S Gamis
1 reference
Soheil Meshinchi
1 reference
Roland B Walter
1 reference
20 October 2015
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference